Cargando…
Is Thymoglobulin or Rituximab the Cause of This Serum Sickness? A Case Report of Serum Sickness Dilemma and Literature Review
Serum sickness is an immune-complex-mediated systemic illness that can occur after treatment with monoclonal or polyclonal antibodies such as Rituxan (Rituximab) or antithymocyte globulin (Thymoglobulin), respectively. Since Rituximab is now being used as an adjuvant treatment for acute humoral reje...
Autores principales: | Sandhu, Amarpreet, Harford, Antonia, Singh, Pooja, Alas, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465905/ https://www.ncbi.nlm.nih.gov/pubmed/23056053 http://dx.doi.org/10.1155/2012/234515 |
Ejemplares similares
-
Rituximab: Serum sickness: case report
Publicado: (2020) -
Dapsone/rituximab: Serum sickness and lack of efficacy: case report
Publicado: (2022) -
Rituximab-Induced Serum Sickness Overlapping With Anaphylaxis: A Case Report
por: Cottu, Adrien, et al.
Publicado: (2023) -
Rituximab-induced serum sickness in the treatment of idiopathic membranous nephropathy
por: Cheong, Jamie, et al.
Publicado: (2018) -
SERUM SICKNESS IN RABBITS : I. MANIFESTATIONS OF SERUM SICKNESS
por: Fleisher, Mover S., et al.
Publicado: (1931)